Buerger's disease laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ahmed Younes (talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 36: | Line 36: | ||
**Others | **Others | ||
***[[Glucose test|Fasting glucose]] | ***[[Glucose test|Fasting glucose]] | ||
***Urine analysis | ***[[Urinalysis|Urine analysis]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 18:54, 1 May 2018
Buerger's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Buerger's disease laboratory findings On the Web |
American Roentgen Ray Society Images of Buerger's disease laboratory findings |
Risk calculators and risk factors for Buerger's disease laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
There are no diagnostic laboratory findings associated with Buerger's disease. Lab testing is done to exclude other vasculitides, such as lupus, scleroderma and mixed connective tissue disease.
Laboratory Findings
- There are no diagnostic laboratory findings associated with Buerger's disease.
- Laboratory testing is performed to exclude other pathologies, and include:[1][2][3]
- Acute phase reactants that indicate an active inflammatory process:
- Immunologic panel to rule out autoimmune disease:
- To rule out hypercoagulability:
- Toxicology screen
- Others
References
- ↑ Olin JW (September 2000). "Thromboangiitis obliterans (Buerger's disease)". N. Engl. J. Med. 343 (12): 864–9. doi:10.1056/NEJM200009213431207. PMID 10995867.
- ↑ Maslowski L, McBane R, Alexewicz P, Wysokinski WE (2002). "Antiphospholipid antibodies in thromboangiitis obliterans". Vasc Med. 7 (4): 259–64. doi:10.1191/1358863x02vm452oa. PMID 12710840.
- ↑ Piazza G, Creager MA (April 2010). "Thromboangiitis obliterans". Circulation. 121 (16): 1858–61. doi:10.1161/CIRCULATIONAHA.110.942383. PMC 2880529. PMID 20421527.